Meltzer LA - Search Results

1

Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis.

Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD. Poms AD, et al. Among authors: meltzer la. Chest. 2013 Jul;144(1):169-176. doi: 10.1378/chest.11-3241. Chest. 2013. PMID: 23348820

2

Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.

Frost AE, Badesch DB, Miller DP, Benza RL, Meltzer LA, McGoon MD. Frost AE, et al. Among authors: meltzer la. Chest. 2013 Nov;144(5):1521-1529. doi: 10.1378/chest.12-3023. Chest. 2013. PMID: 23907471 Clinical Trial.

3

Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.

Farber HW, Miller DP, Meltzer LA, McGoon MD. Farber HW, et al. Among authors: meltzer la. J Heart Lung Transplant. 2013 Nov;32(11):1114-22. doi: 10.1016/j.healun.2013.08.010. Epub 2013 Sep 10. J Heart Lung Transplant. 2013. PMID: 24035189

4

Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY).

Cohan SL, Moses H, Calkwood J, Tornatore C, LaGanke C, Smoot KE, Meka V, Okwuokenye M, Hotermans C, Mendoza JP, Mann MK, Meltzer LA. Cohan SL, et al. Among authors: meltzer la. Mult Scler Relat Disord. 2018 May;22:27-34. doi: 10.1016/j.msard.2018.02.028. Epub 2018 Feb 26. Mult Scler Relat Disord. 2018. PMID: 29524759 Free article. Clinical Trial.

5

Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study.

Kresa-Reahl K, Repovic P, Robertson D, Okwuokenye M, Meltzer L, Mendoza JP. Kresa-Reahl K, et al. Clin Ther. 2018 Dec;40(12):2077-2087. doi: 10.1016/j.clinthera.2018.10.011. Epub 2018 Nov 22. Clin Ther. 2018. PMID: 30470580

6

Corrigendum to "Effectiveness of Delayed-release Dimethyl Fumarate on Clinical and Patient-reported Outcomes in Patients With Relapsing Multiple Sclerosis Switching From Glatiramer Acetate: RESPOND, a Prospective Observational Study" [Clinical Therapeutics 40 (12) (2018) 2077-2087].

Kresa-Reahl K, Repovic P, Robertson D, Okwuokenye M, Meltzer L, Mendoza JP. Kresa-Reahl K, et al. Clin Ther. 2019 Dec;41(12):2662. doi: 10.1016/j.clinthera.2019.06.001. Epub 2019 Jun 27. Clin Ther. 2019. PMID: 31255296 No abstract available.

7

Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS).

Gold R, Giovannoni G, Phillips JT, Fox RJ, Zhang A, Meltzer L, Kurukulasuriya NC. Gold R, et al. Mult Scler. 2015 Jan;21(1):57-66. doi: 10.1177/1352458514537013. Epub 2014 Jul 2. Mult Scler. 2015. PMID: 24990854 Free PMC article.

8

Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.

Phillips JT, Selmaj K, Gold R, Fox RJ, Havrdova E, Giovannoni G, Abourjaily H, Pace A, Novas M, Hotermans C, Viglietta V, Meltzer L. Phillips JT, et al. Int J MS Care. 2015 Sep-Oct;17(5):236-43. doi: 10.7224/1537-2073.2014-069. Int J MS Care. 2015. PMID: 26472945 Free PMC article.

9

Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Infections in Children: A Two-Center Case-Case-Control Study of Risk Factors and Outcomes in Chicago, Illinois.

Logan LK, Meltzer LA, McAuley JB, Hayden MK, Beck T, Braykov NP, Laxminarayan R, Weinstein RA; CDC Epicenters Prevention Program. Logan LK, et al. Among authors: meltzer la. J Pediatric Infect Dis Soc. 2014 Dec;3(4):312-9. doi: 10.1093/jpids/piu011. Epub 2014 Mar 19. J Pediatric Infect Dis Soc. 2014. PMID: 26625451

10

Induced chromosome deletions cause hypersociability and other features of Williams-Beuren syndrome in mice.

Li HH, Roy M, Kuscuoglu U, Spencer CM, Halm B, Harrison KC, Bayle JH, Splendore A, Ding F, Meltzer LA, Wright E, Paylor R, Deisseroth K, Francke U. Li HH, et al. Among authors: meltzer la. EMBO Mol Med. 2009 Apr;1(1):50-65. doi: 10.1002/emmm.200900003. EMBO Mol Med. 2009. PMID: 20049703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page